WEBULL
MARKET

TLX

TLX

Telix Pharmaceuticals Ltd ADR
NASDAQ
7.49
-0.26
-3.35%
After Hours: 7.49 0 0.00% 16:10 12/31 EST
OPEN
7.72
PREV CLOSE
7.75
HIGH
7.73
LOW
7.49
VOLUME
300.55K
TURNOVER
--
52 WEEK HIGH
30.36
52 WEEK LOW
7.49
MARKET CAP
2.51B
P/E (TTM)
152.55
1D
5D
1M
3M
1Y
5Y
1D
21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures
PR Newswire · 5h ago
TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
PR Newswire · 16h ago
Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR Newswire · 12/31/2025 20:41
21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures
PR Newswire · 12/30/2025 14:30
Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) - January 9, 2026 Deadline to Join - Contact Levi & Korsinsky
PR Newswire · 12/30/2025 14:00
Telix Pharmaceuticals Faces Class Action Over Alleged Securities Fraud
Reuters · 12/30/2025 12:42
Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) - January 9, 2026 Deadline to Join - Contact The Gross Law Firm
PR Newswire · 12/29/2025 14:00
Telix Pharmaceuticals Faces Investor Class Action Over Alleged Securities Fraud
Reuters · 12/29/2025 12:47
More
About TLX
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

Webull offers Telix Pharmaceuticals Ltd stock information, including NASDAQ: TLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLX stock methods without spending real money on the virtual paper trading platform.